BACKGROUND: Recent evidence validates the effectiveness of neoadjuvant chemotherapy in the treatment of @entity356 . Endoscopic ultrasonographic (EUS) staging has been proposed as a useful adjunct in this setting. METHODS: We performed a retrospective review of @entity1 treated at our institution for @entity356 between July 2005 and January 2014. We identified @entity1 referred for EUS before surgery as part of a prospective treatment plan. Histopathologic staging was compared to EUS staging, with a focus on T- and N-stage. Agreement between the two modalities was examined using kappa-statistics. RESULTS: We identified 614 @entity1 with biopsy-proven @entity356 ; 145 underwent curative-intent surgery. Surgical pathology and EUS results were available from 69 @entity1 . The accuracy of EUS for the evaluation of T- and N-stage was 44.9% and 56.5%, respectively. EUS demonstrated greater concordance with histopathology at evaluating T-stage (k   =   0.3469) than N-stage (k   =   0.1316). EUS underestimated T- and N-stage in 40.8% and 30.4% of @entity1 , respectively. CONCLUSION: EUS seems to correlate poorly with pathology in the preoperative staging of @entity356 . In the majority of inaccurate cases, EUS underestimates T-stage and N-stage, limiting its utility in the neoadjuvant setting. J. Surg. Oncol.    2016 Wiley Periodicals, Inc.

Correlation between preoperative endoscopic ultrasound and surgical pathology staging of XXXX : A single institution retrospective review.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric adenocarcinoma']
@entity356 :: (MESH:D013274,Disease) :: ['gastric adenocarcinoma']
